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Autosomal dominant polycystic kidney disease is character-
ized by the loss-of-function of a signaling complex involving
polycystin-1 and polycystin-2 (TRPP2, an ion channel of the
TRP superfamily), resulting in a disturbance in intracellular
Ca2 signaling. Here, we identified the molecular determinants
of the interaction between TRPP2 and the inositol 1,4,5-
trisphosphate receptor (IP3R), an intracellular Ca2 channel in
the endoplasmic reticulum.Glutathione S-transferase pulldown
experiments combinedwithmutational analysis led to the iden-
tification of an acidic cluster in the C-terminal cytoplasmic tail
of TRPP2 and a cluster of positively charged residues in the
N-terminal ligand-binding domain of the IP3R as directly
responsible for the interaction.To investigate the functional rel-
evance of TRPP2 in the endoplasmic reticulum, we re-intro-
duced the protein in TRPP2/ mouse renal epithelial cells
using an adenoviral expression system. The presence of TRPP2
resulted in an increased agonist-induced intracellular Ca2
release in intact cells and IP3-inducedCa2 release in permeabi-
lized cells. Using pathological mutants of TRPP2, R740X and
D509V, and competing peptides, we demonstrated that TRPP2
amplified the Ca2 signal by a local Ca2-induced Ca2-release
mechanism, which only occurred in the presence of the TRPP2-
IP3R interaction, and not via altered IP3R channel activity.
Moreover, our results indicate that this interaction was instru-
mental in the formation of Ca2 microdomains necessary for
initiating Ca2-induced Ca2 release. The data strongly suggest
that defects in thismechanismmay account for the alteredCa2
signaling associated with pathological TRPP2 mutations and
therefore contribute to thedevelopment of autosomal dominant
polycystic kidney disease.
Autosomal dominant polycystic kidney disease (ADPKD)4 is
an inherited human disorder that affects more than six million
people worldwide and is themost commonmonogenic cause of
kidney failure in humans (1). ADPKD results in end-stage renal
disease in 50% of the affected individuals by the age of 60.
ADPKD arises as a consequence of mutations of two genes
PKD1 and PKD2, encoding integral membrane proteins poly-
cystin-1 (PKD1, 460 kDa) and polycystin-2 (TRPP2, 110
kDa), respectively. Most mutations identified in affected fami-
lies appear to truncate and (or) inactivate either of both pro-
teins (2–5). Mutations in PKD1 account for the vast majority
(85%) of patientswithADPKDand are associatedwith amore
severe clinical presentation and earlier onset of end-stage renal
disease than the PKD2 phenotype (4). However, in all other
aspects, PKD1 and PKD2mutations produce virtually indistin-
guishable disease manifestations, indicating that the two pro-
teins might function in a common signaling pathway involved
in maintaining the terminally differentiated state of renal epi-
thelial cells.
TRPP2 is a 968-amino acid (aa) protein with six predicted
transmembrane domains and is highly conserved among mul-
ticellular organisms and widely expressed in various tissues (2).
Structural analyses indicate that TRPP2 contains several func-
tional domains in its C-terminal tail. There are two Ca2-bind-
ing sites (aa 680–796) arranged in a typical and an atypical
EF-hand motif, which could be involved in a Ca2-mediated
regulation of TRPP2 (6). An endoplasmic reticulum (ER) reten-
tion signal (aa 787–820) (7) and a coiled-coil domain (aa 839–
919), responsible for homo- and heterodimerization (8, 9), are
also present. Recently, it was reported that this coiled-coil
domain was responsible for formation of a TRPP2 trimer that
interacts with PKD1 in the plasma membrane (9).
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There is a long-standing debate on the subcellular localiza-
tion of TRPP2. TRPP2 has been detected (i) in the plasmamem-
brane, where it is supposed to form a receptor-operated, non-
selective cation channel (10), (ii) in the primary cilium, where it
could act as amechanosensitive channel, possibly in association
with PKD1 (11), TRPC1 (12, 13), or TRPV4 (11, 14), (iii) in the
ER, where it is proposed to function as an intracellular Ca2-
release channel (15), but also in centrosomes and mitotic spin-
dles of dividing cells (reviewed in Refs. 16–18). The trafficking
of TRPP2 to these specific subcellular compartments is regu-
lated by (i) specificmotifswithin the protein (7, 19), (ii)multiple
protein-protein interactions, e.g. with phosphofurin acidic
cluster sorting proteins 1 and 2 (20), and (iii) a casein kinase
2-mediated phosphorylation of Ser812 in the C terminus of
TRPP2 (20, 21). However, the predominant subcellular local-
ization of TRPP2 is in the ER, as shown by sensitivity to EndoH,
immunofluorescence, co-localization, and co-distribution with
ER-resident proteins (7, 15).
Interaction between TRPP2 and the two major intracellular
Ca2-release channels, the ryanodine receptor (RyR), and the
inositol 1,4,5-trisphosphate receptor (IP3R), has been reported.
Biochemical and functional assays have demonstrated that the
N-terminal part of TRPP2 is sufficient to bind the cardiac RyR2,
whereas the C-terminal part of TRPP2 can only bind to RyR2
when it is in the open state, thereby inhibiting RyR function
(22). Co-immunoprecipitation assays indicated that TRPP2
physically interacts with the IP3R1, most likely through its
C-terminal part (23). Recently Li et al. (24) demonstrated also
that ER-localized PKD1 can interact with the IP3R, thereby
inhibiting IP3-induced Ca2 release (IICR). Several studies
observed an enhancement of intracellular Ca2 release thatwas
attributed to an effect of TRPP2 (15, 23, 25, 26), but the physi-
ological mechanism of action was not elucidated. On the other
hand, Wegierski and co-workers (27) observed that TRPP2
could also act as a passive Ca2-leak channel in the ER, thereby
lowering the Ca2 concentration in the ER ([Ca2]ER), which
resulted in an opposite effect and decreased the magnitude of
IICR. These controversial results illustrate that the exactmech-
anism through which polycystins in general and TRPP2 in par-
ticular modulate Ca2 signaling is not yet understood. We
therefore performed a detailed analysis of the molecular and
functional relationship between the IP3R and TRPP2.
Here, we identified a conserved positively charged cluster in
the N-terminal suppressor domain of the IP3R and an acidic
cluster located at the end of the ER-retention signal in the
C-terminal tail of TRPP2 as being crucial for the interaction
between both proteins.Moreover, in a background of renal epi-
thelial TRPP2/ cells, we observed a clear potentiation of both
ATP-induced intracellular Ca2 release in intact cells and IICR
in permeabilized cells upon TRPP2 re-introduction. Further
analysis using pathologicalmutants of TRPP2 and peptides that
compete with the interaction between TRPP2 and the IP3R
revealed that the observed increase in IICR required both a
functional TRPP2 channel and a physical interaction with the
IP3R. We suggest that TRPP2 functions as a tightly regulated
channel in the ER that participates in an intracellular signaling
complex together with the IP3R, thereby stimulating intracel-
lular Ca2 release within a microdomain in the immediate
neighborhood of these interacting proteins.
EXPERIMENTAL PROCEDURES
Materials—Isopropyl -D-thiogalactoside, bovine serum
albumin, carbonyl cyanide 4-trifluoromethoxyphenylhydra-
zone, IP3, and ionomycin were from Sigma. Fura2-AM was
from TEFlabs (Austin, TX). MagFluo4-AM, nickel-nitrilotri-
acetic acid-agarose resin, NuPAGE gels, NuPAGE loading dye
solution sample buffer, MOPS buffer, the Virapower kit, gene-
ticin, all cell culturemedia, and supplementswere from Invitro-
gen. ATP was from Roche Applied Science. Thapsigargin (TG)
was from Alexis (Zandhoven, Belgium). Glutathione-Sepha-
rose 4B, secondary antibodies coupled to horseradish peroxi-
dase, Enhanced Chemiluminescence (ECL) reagents, and
Hyperfilms were from GE Healthcare. r-Protein A-TSK resin
was from Affiland (Lie`ge, Belgium). Immobilon-P polyvinyli-
dene fluoridemicroporous transfermembraneswere fromMil-
lipore (Billerica, MA). 96-Well culture plates (CELLSTAR,
black polystyrene, Clear flat bottom with lid) were from
Greiner (Wemmel, Belgium). The QuikChange Site-directed
Mutagenesis kit was from Stratagene (La Jolla, CA). Slide-A-
Lyzer dialysis cassettes and peptides were from Thermo Fisher
Scientific (Ulm, Germany). Peptides were synthesized with a
purity of 70% and verified by mass spectrometry and high
pressure liquid chromatography.
DNAConstructs and Adenovirus Construction—The original
cDNA of mouse wild-type TRPP2, which was subcloned in a
pcINeo/IRES-GFP vectorwith aC-terminalmyc tag, was a kind
gift fromDr. V. Gerke, University of Mu¨nster, Germany. Using
this construct we generated an LLC-PK1 cell line (porcine
renal epithelial cells) stably expressing wild-type TRPP2 by
geneticin selection and subsequent fluorescence-activated
cell sorter selection of a green fluorescent protein-express-
ing cell population.
An adenovirus was produced using the Virapower kit from
Invitrogen for wild-type TRPP2 and two pathological mutants
D509V and R740X. A control virus was made starting from the
empty pAD/PL-DEST vector. Using Gateway technology first a
pDONR221-TRPP2 wild-type construct under control of a
cytomegalovirus promoter was made via a BP recombination
reaction (between attB- and attP-containing substrates). Sub-
sequently an LR recombination reaction (between attL- and
attR-containing substrates) was performed to obtain destina-
tion vector pAd/PL-DEST-TRPP2. These were then trans-
fected using Lipofectamine in HEK 293A cells, which were
genetically modified and include human adenovirus type-5
DNA, to facilitate production of adenovirus. The TRPP2
D509V and R740X mutants were made by site-directed
mutagenesis by introducing GTT (V) to replace GAT (D) at
codon 509, and TAG (Stop) to replace CGG (R) at codon 740,
respectively, with wild-type pDONR221-TRPP2 as donor
DNA. The different domains of the IP3R1 (domains 1 to 6), the
complete ligand-binding domain (LBD, aa 1–604), and the sup-
pressor domains (aa 1–225) of IP3R1 and IP3R3were subcloned
in the bacterial pGEX-6p2 vector with an N-terminal glutathi-
one S-transferase (GST) tag, as previously described (28, 29).
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The cDNA fragments corresponding to the complete cyto-
solic N terminus (TRPP2-NT, aa 1–221) and C terminus
(TRPP2-CT, aa 679–966) of TRPP2 were subcloned into the
bacterial pET21b andpGEX-6p2 vector, to obtainHIS- orGST-
tagged proteins, respectively. All constructs were sequenced on
a Genetic Analyzer 3100 using Big Dye Terminator V1.1 tech-
nology (Applied Biosystems, Foster City, CA).
Cell Culture—TRPP2/ (2D2) renal proximal tubulus epi-
thelial cells were derived from a TRPP2/WS25 mouse, trans-
genic for the SV40 large T-antigen (30). The cells were isolated
and cultured as previously described (31). Cells were trans-
duced by adding the adenovirus to the normal cell culture
medium. For transduction of the cells, viral titers were deter-
mined for wild-type TRPP2 (1/1000), TRPP2 D509V (1/704),
and TRPP2 R740X (1/1124) to obtain an equal amount of pro-
tein expression, as assayed byWestern blotting.We chose in all
functional experiments a moderate overexpression using the
adenoviral system, mimicking endogenous levels in wild-type
kidney cells instead of a massive overexpression of the protein,
to avoid induction of ER stress responses.
Antibodies—For wild-type TRPP2, a mouse monoclonal
antibody (sc-28331) (Santa Cruz Biotechnology Inc., Santa
Cruz, CA) directed against its C-terminal tail (aa 689–968) was
used at a dilution of 1/1000 inWestern blotting analysis. Addi-
tionally, a rabbit polyclonal antibody directed against the N
terminus (aa 103–203) (YCB9) was a kind gift fromDr. Cai and
Dr. Somlo and was used to recognize wild-type TRPP2 and the
D509V and R740X mutants (7). This antibody was used at a
1/5000 dilution for Western blotting analysis and 1/500 dilu-
tion for immunofluorescence. The mouse monoclonal anti-
body (610312) that specifically recognizes IP3R3 (aa 22–230)
was from BD Biosciences (Pharmingen), and used at a 1/1000
dilution inWestern blotting. Immunological detection of IP3R1
was carried out using aRbt03 polyclonal antibody raised against
C-terminal amino acids 2735–2749 of mouse IP3R1 (32), at a
1/3000 dilution inWestern blotting. For immunological detec-
tion of the recombinant HIS fusion proteins, a horseradish per-
oxidase-conjugated Penta-HIS antibody was used fromQiagen
(Venlo, The Netherlands).
Immunoprecipitation—LLC-PK1cellsstablyexpressingwild-
type TRPP2 were lysed in lysis buffer (50 mM Tris, 0.3 M NaCl,
1% Triton, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl
fluoride, 0.5 mM benzamidine, 5 M leupeptin, pH 7.5). The
lysate (200 g/sample) was cleared by centrifugation (5 min,
10,000  g, 4 °C). Supernatants were incubated for 90 min at
4 °C while gently mixing (1400 rpm) with antibodies (1.5g):
(i) anti-TRPP2 (Santa Cruz Biotechnology Inc.), (ii) anti-IP3R1,
(iii) anti-IP3R3, (iv) nonspecific mouse IgG (Santa Cruz Bio-
technology Inc., sc-2025), or (v) nonspecific rabbit IgG (Santa
Cruz Biotechnology Inc., sc-2027). Subsequently, r-protein
A-TSK-Sepharose resin (50% in lysis buffer) was added and
incubation was continued for another hour. Beads were col-
lected by centrifugation (20 s, 2000 g) and washed once with
Tris-buffered saline (TBS) supplemented with 0.25% Triton
X-100 and 0.1 M LiCl and three times with TBS supplemented
with 0.25% Triton X-100. Finally, the beads were resuspended
in 30 l of NuPAGE loading dye solution sample buffer and
heated for 10 min at 75 °C. Supernatants were further analyzed
by SDS-PAGE and Western blotting.
Preparation of GST or HIS Fusion Proteins—pGEX-6p2 and
pET21b constructs were transformed into BL21 Escherichia-
coli. Colonies were grown overnight in 50 ml of dYT medium
(16 g/liter of peptone, 10 g/liter of yeast extract, 5 g/liter of
NaCl, pH 7.4) at 37 °C. dYT medium (400 ml) was added to
this preculture, and bacteria were further grown at 28 °C until
A600 reached 0.8–1. Protein expression was induced by adding
0.1mM isopropyl-D-thiogalactoside and bacteria were further
grown at 28 °C for 4–8h or at 14 °C for 20 h. Bacterial cells were
harvested and lysed by sonication (9  10 s, 12 kHz). Lysates
were cleared by centrifugation (30min, 15,000 g). The soluble
fractions were then incubated during 2 h with glutathione-
Sepharose 4B or nickel-nitrilotriacetic acid-agarose beads at
4 °C. After washing the beads, fusion proteins were eluted with
10 mM glutathione or 250 mM imidazole, respectively. Purified
proteins were dialyzed overnight against TBS, using Slide-A-
Lyzer dialysis cassettes with a cut-off of 10 kDa.
GST Pulldown—Purified and dialyzed GST fusion proteins
or parental GST (control) were incubated with purified and
dialyzed HIS fusion proteins or a cleared lysate from LLC-PK1
cells expressing TRPP2 in pulldown buffer (50 mM Tris, 1 mM
EGTA, pH 7.4) and immobilized on glutathione-Sepharose 4B
beads via rotation in a head-over-head rotator for 1–2 h at 4 °C.
The beads were washed 4 times with pulldown buffer and com-
plexed GST fusion proteins were eluted in 100 mM glutathione
in pulldown buffer. Eluates were further analyzed using SDS-
PAGE and Western blotting.
SDS-PAGE and Western Blotting—Protein samples were
analyzed by NuPAGE 4–12% BisTris SDS-polyacrylamide gels
usingMOPS buffer. After semi-dry electroblotting onto a poly-
vinylidene fluoride membrane, blocking with TBS containing
0.1% Tween and 5% nonfat dry milk powder or bovine serum
albumin, and incubationwith primary antibody (inTBS supple-
mented with 0.1% Tween and 1% nonfat dry milk powder), the
blots were incubated with the horseradish peroxidase-conju-
gated secondary antibodies (in TBS supplemented with 0.1%
Tween and 1% nonfat dry milk powder). The immunoreactive
bands were visualized with ECL substrate and exposed to
Hyperfilm. The Hyperfilm was developed using a Kodak
X-Omat 1000 (Kodak). Total protein content was visualized by
Ponceau red staining of the blot after film development. Quan-
tification was done with ImageJ software (rsbweb.nih.gov/ij/).
[Ca2] Measurements—For measurements of the free cyto-
solic [Ca2] ([Ca2]cyt) in intact cells, the cells were loadedwith
Fura2-AM (1.25 M) in modified Krebs buffer (130 mM NaCl,
4.7 mM KCl, 1.2 mM MgCl2, 1.5 mM CaCl2, 10 mM glucose, 10
mMHepes, pH 7.4) for 45 min at room temperature. This solu-
tionwas then replaced by amodifiedKrebs buffer withoutCa2
indicator and the incubation continued for 30–45min, to allow
de-esterification of the loaded dye. 3 mM EGTA was added
before each measurement to buffer all free extracellular Ca2.
Subsequently, agonist (ATP) or 1 M ionomycin were added to
induce Ca2 release from intracellular stores. Fluorescence
emission was measured at 510 nm with excitation at 340/380
nm. [Ca2]cyt was derived after in situ calibration according to
the following equation: [Ca2]cyt (nM) KdQ (R Rmin)/
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(Rmax R); Kd is the dissociation constant of Fura2 for Ca2 at
room temperature (220 nM), Q is the fluorescence ratio of the
emission intensity excited by 380 nm in the absence of Ca2 to
that during the presence of saturating Ca2, R is the fluores-
cence ratio, Rmin and Rmax are the minimal and maximal fluo-
rescence ratios, respectively. Rmin was measured by perfusion
with 10 mM EGTA in Ca2-free Krebs solution and Rmax was
obtained by perfusionwith 5M ionomycin and 5mMCaCl2. By
integrating the traces in Origin 7 (OriginLab Corporation,
Northampton, MA), the area under the curve was determined
and expressed in arbitrary units.
To measure the free [Ca2]ER, the cells were loaded with 20
MMagFluo4-AM in Hepes-buffered saline (135 mMNaCl, 5.9
mM KCl, 11.6 mM Hepes, 1.5 mM CaCl2, 11.5 mM glucose, 1.2
mM MgCl2, pH 7.4) supplemented with 1 mg/ml of bovine
serum albumin and 0.2 mg/ml of Pluronic F127 (Invitrogen) as
described in Ref. 33. After 60 min, cells were permeabilized in
Ca2-free cytosol-likemedium containing 20g/ml of saponin
(10 min at room temperature). Ca2-free cytosol-like medium
had the following composition: 140mMKCl, 20mMNaCl, 1mM
EGTA, 2 mM MgCl2, 20 mM Pipes, pH 7.0. Subsequently the
solution was replaced with cytosol-likemediumwithoutMg2,
but supplemented with carbonyl cyanide 4-trifluoromethoxy-
phenylhydrazone (10 M) and 375 M CaCl2 to give a free
[Ca2] of 220 nM. 1.5 mM Mg-ATP was added at the beginning
of each measurement to load the ER with Ca2 via the sarco-
plasmic/endoplasmic-reticulum Ca2-ATPase pumps. Upon
reaching a maximal loading, IP3 or ionomycin were added to
the cells together with 10 M TG to prevent re-uptake of Ca2
into the ER. Results are calculated as F/F0 of fluorescence emis-
sion at 525 nm after excitation at 490 nm.
Fluorescence was measured using a 96-well microplate
reader equipped with automated fluid additions (FlexStation 3,
Molecular Devices, Sunnyvale, CA). All experiments were per-
formed at room temperature.
Confocal Imaging—Confocal images were made with an
LSM510 confocal system on a Zeiss Axiovert 100Mmicroscope
(Carl Zeiss Meditec Inc., Jena, Germany) with a 488-nm argon
and 543-nm HeNe laser. The 40
plan neofluar, oil-immersion 1.3
NA, DIC objective was used. The
images were analyzed with Zeiss
LSM Software Release 4.2.
RESULTS
Full-length TRPP2 Interacts with
Endogenous Full-length IP3R1 or
IP3R3—To investigate whether full-
length TRPP2 and the IP3R directly
interact in intact cells, we per-
formedco-immunoprecipitationex-
periments (Fig. 1). An LLC-PK1 cell
line stably expressing full-length
wild-type TRPP2 was used. After
cell lysis, immunoprecipitation was
performed with an antibody against
the C terminus of TRPP2. Specific
association between TRPP2 and
endogenous full-length IP3R3 or IP3R1 was detected by West-
ern blotting analysis (Fig. 1A). The control experiment was per-
formed with nonspecific mouse or rabbit IgG. Furthermore,
when an antibody specifically against IP3R1 or IP3R3 was used
for immunoprecipitation, we also identified TRPP2 in the pre-
cipitate byWestern blotting analysis (Fig. 1B). Due to the insuf-
ficient quality of the antibodies available against IP3R2, we
could not detect or immunoprecipitate IP3R2. The data in Fig. 1
indicate that TRPP2 interacts with both IP3R1 and IP3R3, the
latter being the most abundant isoform in LLC-PK1 cells.
Interaction between TRPP2 and the N-terminal Ligand-bind-
ing Domain of the IP3R1—Each of the four IP3Rmonomers can
be functionally divided in an N-terminal LBD that binds IP3, a
central regulatory/coupling domain and a C-terminal channel
and gatekeeper domain (reviewed in Ref. 34). The N-terminal
LBD (aa 1–604) can be functionally and structurally subdivided
into a suppressor domain (aa 1–225) and an IP3-binding core
(aa 226–604) (35). A linear representation of the IP3R is
depicted in Fig. 2A.We have employedGST pulldown assays to
further characterize the TRPP2-IP3R interaction. To map the
TRPP2-binding site on the IP3R, we used a series of GST-IP3R
fusion proteins corresponding to five fragments covering the
first N-terminal 2216 amino acids and 1 fragment correspond-
ing to the last C-terminal 160 amino acids of mouse IP3R1 (28,
29). These fragments are located in the cytoplasm and coincide
with “natural” domains generated by limited proteolysis, but
the transmembrane domain was not included (36). In addition
to these six domains, we used aGST fusion protein covering the
complete LBD (aa 1–604). After purification, the recombinant
proteins migrated as prominent bands corresponding to their
expected molecular weights (Fig. 2B). Lysates obtained from
the LLC-PK1 cells stably expressing TRPP2 were incubated
with theGST-IP3R fragments pre-bound to glutathione-Sepha-
rose 4B resin, with equal loading of the GST-IP3R fragments.
After pulldown and elution, the samples were processed by
SDS-PAGE. TRPP2 was visualized using the mouse mono-
clonal antibody against TRPP2 (Fig. 2B). Full-length TRPP2
mainly interacted with the complete N-terminal LBD of the
FIGURE1.Co-immunoprecipitationof full-lengthTRPP2and IP3R.A, co-immunoprecipitation (IP) of endog-
enous IP3R3 and IP3R1 with TRPP2 in TRPP2-expressing LLC-PK1 cells. The upper immunoblot (IB) shows the
staining for TRPP2, whereas the lower immunoblots show the staining for IP3R3 and IP3R1. B, co-immunopre-
cipitation of TRPP2 with endogenous IP3R1 or IP3R3. The upper immunoblot shows the staining for TRPP2, the
middle immunoblot shows the staining for IP3R3 and the lower immunoblot shows the staining for IP3R1.
Representative immunoblots from three independent experiments are shown.
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IP3R (aa 1–604) and with domain 1 (aa 1–345), which is part of
this LBD (Fig. 2B, lower panel). The interaction was specific, as
TRPP2 did not interact with the parental GST.
A Positively Charged Cluster in the Suppressor Region of the
LBD of the IP3R Interacts with an Acidic Cluster in the C-termi-
nal Cytoplasmic Tail of TRPP2—Previous work in our labora-
tory identified a cluster of positively charged residues (aa
51–54) in the suppressor domain of the IP3R1,5 conserved
among all three IP3R isoforms, that were critical for interaction
with negatively charged protein sequences, as e.g. in calmodulin
(37). We therefore hypothesized that this positively charged
cluster may be involved in the interaction with TRPP2, which
contains a highly negatively charged cluster in the C-terminal
cytoplasmic tail. We mutated two lysine residues and one argi-
nine residue within this positive cluster to negatively charged
aspartate residues (KKFR54 to DDFD54) in the GST-LBD con-
struct (GST-LBD DDFD54). Pulldown with GST fusion pro-
teins of the LBDand the LBDDDFD54 indicated that full-length
TRPP2 could interact with GST-LBD but not with GST-LBD
DDFD54 (Fig. 2C).
Furthermore, an additional mutant of the LBD was made by
mutating the three positively charged residues to neutral resi-
dues (KKFR54 to AAFA54) to avoid the too drastic structural
changes that can occur by the mutations to negatively charged
residues. To identify the region of TRPP2 required for interac-
tion with IP3R1, recombinant His6 fusion proteins of the com-
plete cytosolic N- (aa 1–221)
(TRPP2-NT-HIS) and C-terminal
part (aa 679–966) (TRPP2-CT-HIS)
ofTRPP2were bacterially expressed
and purified. Pulldown assays with
GST-LBD and both GST-LBD
mutants revealed a clear interaction
between GST-LBD and TRPP2-CT
(Fig. 3A). Like the full-length
TRPP2, the interaction with GST-
LBD DDFD54 was abolished. Addi-
tionally, interaction with GST-LBD
AAFA54 was similarly abolished. In
contrast to TRPP2-CT, TRPP2-NT
could neither specifically interact
with the LBD nor with its mutants
(Fig. 3A), indicating that the C-ter-
minal tail of TRPP2 is the major
determinant for binding to the sup-
pressor domain of the IP3R. We
then tested whether IP3 could alter
the interaction between the IP3R
and TRPP2, but this was not the
case (supplemental Fig. S1). To con-
firm the interactionwith both IP3R1
and IP3R3, a pulldown was per-
formed between full-length TRPP2
or TRPP2-CT-HIS and the suppres-
sor domains (aa 1–225) of IP3R1 and
IP3R3, fused to GST (Fig. 3B). Both
suppressor domains could pull down TRPP2, both full-length
TRPP2 or only its C terminus. TRPP2-CT contains an acidic
cluster (aa 810–818 SEEEDDEDS) located at the end of the ER
retention signal, well conserved among chordates but absent in
polycystin-2 like-1 (PKD2L1 or TRPP3) and -2 (PKD2L2 or
TRPP5) (supplemental Fig. S2). A casein kinase 2-phosphory-
lation site (Ser810 in the mouse sequence, corresponding to
Ser812 in the human sequence) is located within this cluster and
has been shown to be important for channel regulation (25).
This cluster is also involved in interactions with other proteins
(20, 38). To test whether this acidic cluster is implicated in
interaction with the IP3R, peptides containing this cluster were
synthesized. A peptide representing the acidic cluster (SLDD-
SEEEDDEDSGH) (AC), a phosphomimic mutant (SLD-
DDEEEDDEDSGH) (AC S810D), and a mutant peptide with
four alanine mutations replacing the negatively charged amino
acids (SLDDAEEAAAEDSGH) (ACmutant) were used in GST
pulldown assays to compete for the interaction between
TRPP2-CT-HIS andGST-LBD. As shown in Fig. 3C, increasing
amounts of the AC peptide competed for binding of TRPP2-
CT-HIS to GST-LBD. Also the phosphomimic peptide, which
contains an extra negative charge, could clearly disrupt the
interaction, even more effectively than the wild-type AC pep-
tide (a residual binding of 18 versus 44%). The ACmutant pep-
tide, which lacks several negative residues, did not interfere
with the binding of TRPP2-CT-HIS to GST-LBD. We investi-
gated further whether interaction was purely electrostatic or
sequence-specific using a scrambled peptide of the acidic clus-
5 B.Devogelaere,N.Nadif Kasri, E. Sammels,G. Bultynck, L.Missiaen, J. B. Parys,
and H. De Smedt, unpublished results.
FIGURE 2.GST pulldowns using purified IP3R subdomains and full-length TRPP2. A, linear structure of the
IP3R1: LBD, regulatory domain, and the channel pore. The LBD canbe further divided into a suppressor domain
(aa 1–225) and an IP3-binding core (aa 226–604). GST is N-terminal fused to the LBD and to the six cytoplasmic
domains of the IP3R1. B, GST pulldown using the different domains of the IP3R1, bacterially expressed and
purified as GST fusion proteins, and full-length TRPP2, obtained from LLC-PK1 cells stably expressing TRPP2.
The upper panel shows Ponceau red staining of the input proteins. The lower immunoblot shows the staining
for TRPP2. The arrows indicate the bands with specific interaction. C, pulldown between GST-LBD or GST-LBD
mutant (KKFR54 is mutated to DDFD54) and full-length TRPP2, obtained from LLC-PK1 cells stably expressing
TRPP2. The immunoblot shows the staining for TRPP2. The short parallel lines indicates the position where a
lane was moved from within the same blot.
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ter (AC Scr) in GST pulldown assays (Fig. 3D). Addition of the
scrambled acidic cluster peptide resulted in partial disturbance
of the interaction betweenGST-LBD andTRPP2-CT, however,
to a much lesser extent than the acidic cluster peptide. This
finding demonstrates that the interaction is primarily based on
electrostatic charges but that the exact location of these charges
is also important and leads to a sequence-specific effect. Taken
together, these data indicate that the acidic cluster in the C-ter-
minal tail of TRPP2 and the positively charged cluster in the
suppressor domain of the IP3R are crucial for interaction
between the two proteins.
TRPP2 Potentiates ATP-induced Intracellular Ca2 Release
in IntactCells—Tostudy the effect of thismolecular interaction
on intracellular Ca2 signaling, we used a TRPP2/ renal epi-
thelial cell line derived fromTRPP2/WS25mice (30) represent-
ing a zero-background system to study the effects mediated by
wild-typeTRPP2 orTRPP2mutants. To re-introduceTRPP2 in
these cells with high efficiency and an adjustable level of expres-
sion, we constructed an adenovirus encoding TRPP2. As
shown on the Western blot and the confocal images
(supplemental Fig. S3), the expression level of TRPP2 corre-
lated with the virus titer. Adenoviral expressed TRPP2 was
mainly localized in the ER. We chose a moderate TRPP2
expression, comparable with the endogenous levels of TRPP2
in renal epithelial cells (as shown in supplemental
Fig. S4, lanes 1 and 4). This also excludes the need for making
stable cell lines and the risk for concomitant selection of com-
pensatory mutants. TRPP2/ cells were transduced with a
control virus or a TRPP2 virus to re-introduce wild-type
TRPP2, and cultured in 96-well plates. In intact cells, we exam-
ined the intracellular Ca2 release upon agonist (ATP) addition
by monitoring the [Ca2]cyt in a microplate reader. Extracellu-
lar Ca2 was buffered by addition of 3 mM EGTA at the begin-
ning of each assay. For each ATP concentration (500 nM, 1 M,
and 10 M), a significant potentiation of the Ca2 release was
observed in cells expressingTRPP2 comparedwith cells treated
with the control virus (Fig. 4A, black and red traces). Both the
amplitude (Fig. 4B) and the area under the curve (Fig. 4C) were
significantly increased for all three ATP concentrations used.
At a maximal dose of ATP (100 M) there was, however, no
longer a difference in Ca2 release between the cells expressing
TRPP2 compared with the cells treated with control virus
(supplemental Fig. S5). The maximal releasable Ca2 induced
by 1 M ionomycin was also not significantly altered (Fig. 4).
TRPP2 Potentiates IICR in Permeabilized Cells—The effect
of TRPP2 on IICR was measured in plasma membrane-perme-
abilized cells loaded with the ER-resident Ca2 indicator Mag-
Fluo4. There was no significant difference in the loading of the
ERwith Ca2 prior to the addition of IP3 in cells treated with (i)
a control virus, (ii) a TRPP2 virus, (iii) a TRPP2 D509V virus,
and (iv) a TRPP2 R740X virus (discussed later) (supple-
mental Fig. S6). Therefore, the F/F0 data were normalized by
setting the maximal [Ca2]ER (as F/F0) prior to the IP3 addition
at 100%.
TG (10 M) alone was added to investigate whether TRPP2
couldmediate a passive leak of Ca2 from the ER.We could not
detect a significant difference in the rate of [Ca2]ER decrease
between control cells and cells expressingTRPP2 (Fig. 5A). Fur-
FIGURE 3. Identification of the sequences involved in the interaction between TRPP2-CT and IP3R-LBD. A, GST pulldown using GST, GST-LBD, GST-LBD
DDFD54, or GST-LBD AAFA54, and TRPP2-CT-HIS or TRPP2-NT-HIS. The upper panel shows Ponceau red staining of the input GST fusion proteins. The lower
immunoblots show the staining for the HIS fusion proteins. B,GST pulldown using GST or GST-suppressor (aa 1–225) of IP3R3 or IP3R1 and full-length TRPP2 or
TRPP2-CT-HIS. The upper panel shows Ponceau red staining of the input GST fusion proteins. The lower immunoblots show the staining for TRPP2-CT-HIS or
full-length TRPP2. C, GST pulldown using GST-LBD and TRPP2-CT-HIS in the presence of acidic cluster peptide (AC) (10, 50, and 100 M), the phosphomimic
S810D peptide (AC S810D) (50 M), and the mutant peptide where four negatively charged residues are replaced by alanine (AC mutant) (50 M). The upper
immunoblot shows Ponceau red staining of the input proteins. The lower immunoblot shows the staining for TRPP2-CT-HIS. The quantification is averaged for
three independent experiments and expressed in percent of the binding in the absence of peptides (mean  S.E.). D, GST pulldown using GST-LBD and
TRPP2-CT-HIS in the presence of 100 M mutant acidic cluster peptide (AC mutant), scrambled acidic cluster peptide (AC Scr), and acidic cluster peptide itself
(AC). The upper immunoblot shows Ponceau red staining of the input proteins. The lower immunoblot shows staining for TRPP2-CT-HIS. The quantification is
averaged for three independent experiments and expressed in % of the binding in the absence of peptides (mean S.E.).
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thermore, also in intact cells, we could not detect a significant
difference in the rate of [Ca2]cyt rise between control cells and
cells expressing TRPP2 (supplemental Fig. S7) and themaximal
ER Ca2 content was not changed (supplemental Fig. S7,
100 s). The maximal releasable Ca2 in permeabilized cells,
determined by adding 1 M ionomycin, was the same for
both conditions (Fig. 5A). However, TRPP2 potentiated
IICR, because there was increased IICR in cells expressing
TRPP2 compared with cells treated with the control virus
(without TRPP2) when submaximal doses of IP3 were
applied (Fig. 5B). Application of a saturating dose of IP3 (100
M) no longer resulted in increased IICR in cells expressing
TRPP2. A complete dose-response curve was fitted accord-
ing to the Hill equation. The Hill coefficient and Vmax
remained unchanged, but the EC50 significantly changed
from 5.77 0.39M IP3 in control cells to 3.09 0.05M IP3
in cells expressing TRPP2 (p 	 0.05) (Table 1).
Stimulation of IICR Is Dependent on TRPP2-channel Func-
tion and Interaction with the IP3R—To elucidate whether
TRPP2 channel activity was involved in this effect on IICR, we
made a D509V TRPP2 mutant. This pathological missense
mutation of a single amino acid in the third membrane-span-
ning domain results in complete loss of TRPP2 channel activity
(15). This mutant retained the ER localization and C-terminal-
mediated protein interactions and regulatory domains. A sec-
ond pathological R740X-truncated mutant, which lost the
interaction site with the IP3R, was made to verify whether the
effect on IICR was dependent on the interaction between
TRPP2 and IP3R. This mutant still showed channel activity,
although some channel properties like the regulation by Ca2
FIGURE 4. Effect of TRPP2 andmutants on agonist-induced Ca2 release in intact cells. TRPP2/ cells were treated with either control virus (black) (titer
1/1000) or a TRPP2 virus to re-introduce wild-type TRPP2 (red) (titer 1/1000) or mutants D509V (green) (titer 1/704) and R740X (blue) (titer 1/1124). The ratio of
emitted fluorescence of Fura2wasmonitored and the three different [ATP] or 1M ionomycinwere added as indicated in the presence of 3mMEGTA. [Ca2]cyt
was derived after in situ calibration. Panel A shows the averaged traces of at least three independent experiments. Panel B shows the increase in [Ca2]cyt (nM)
after agonist addition, averaged for at least three independent experiments. Panel C shows the quantification of the area under the curve in arbitrary units
(A.U.). Results are shown as mean  S.E. Statistically significant differences are labeled with: *, p 	 0.05, and **, p 	 0.01, using a Student’s t test (paired
two-tailed).
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are altered, possibly due to loss of the EF-hand (15, 39). In
supplemental Fig. S4, the adenoviral expression and subcellular
localization ofwild-typeTRPP2 and the twomutants are shown
on a Western blot and in confocal images. In contrast to wild-
type TRPP2, none of the mutants potentiated intracellular
Ca2 release in intact cells upon addition of 500 nM, 1M, or 10
M ATP compared with control cells (Fig. 4). The maximal
releasable Ca2 induced by 1 M ionomycin was not signifi-
cantly different.
Also in permeabilized cells, IICR was no longer potentiated
in cells expressing the mutants as compared with wild-type
TRPP2 (Fig. 6A). The decrease of the [Ca2]ER upon addition of
3 M IP3 is shown. This value amounted to 27.5  2.1% in
control cells, 38.9  2.7% in TRPP2-expressing cells, 25.3 
1.4% in TRPP2 D509V-expressing cells, and 26.0  1.2% in
TRPP2 R740X expressing cells (Fig. 6A). The experiment with
the channel-dead mutant indicates that the potentiation of
IICR was dependent on TRPP2 channel activity. The results
with the R740Xmutant suggest also that theTRPP2-IP3R inter-
action was needed for this potentiation of IICR, although it
cannot be completely excluded that the loss of potentiation of
IICRwas due to altered TRPP2 channel properties. Therefore a
second approachwas used to validate the role of the interaction
between TRPP2 and the IP3R in intracellular Ca2 signaling
(Fig. 6B). Disruption of the interaction between TRPP2 and
IP3R by addition of the AC peptide (cf. Fig. 3C) prevented
potentiation of IICR in TRPP2-expressing cells in response to 1
M IP3, whereas this potentiation was not prevented by AC
mutant peptide (Fig. 6B). These peptides had no effect on IICR
in control cells. These results confirm that an interaction
between TRPP2 and IP3R was required to potentiate intracel-
lular Ca2 release upon IP3R activation.
We hypothesize that TRPP2 can be activated by an initial
IICR via a Ca2-induced Ca2-release (CICR) mechanism. To
substantiate this hypothesis, we used BAPTA, a faster Ca2
buffer than EGTA, at a high concentration (20 mM BAPTA
instead of 1mMEGTA) in theCa2 assay in permeabilized cells.
Under these conditions, TRPP2 no longer potentiated the IICR
after addition of 5M IP3 (Fig. 6C). It is noted that the extent of
the release was lower when using BAPTA buffering, compared
with EGTA buffering. The reason for this is that BAPTA can
slightly inhibit IICR (40). To further rule out that TRPP2 did
not simply function as an additional CICR mechanism but
required an initial IICR, we applied submaximal doses of iono-
mycin in intact and permeabilized cells. This provoked a gen-
eral rise in [Ca2]cyt and a decrease in [Ca2]ER, but there was
no potentiation of the Ca2 release in cells expressing TRPP2,
compared with cells treated with the control virus (Fig. 7). We
therefore conclude that a local Ca2 release as produced by IP3
is required for inducingCICRviaTRPP2,whereas a globalCa2
increase as by ionomycin cannot produce this CICR.
Taken together, these data suggest that TRPP2 and the IP3R
form a signaling complex at the ER, thereby fine-tuning and
coordinating Ca2 signaling in a microdomain of intracellular
Ca2 release. The close proximity of TRPP2 channels and IP3Rs
in a protein complex thereby allows the amplification of IP3R
originating Ca2 signals via a local CICR mechanism.
DISCUSSION
The main finding of this study was that endogenous TRPP2-
IP3R signaling complexes are responsible for the TRPP2-de-
pendent potentiation of IICR. The novel findings in this work
are: (i) the identification of residues responsible for the interac-
tion, on TRPP2 as well as on the IP3R, which can now be tar-
geted to disrupt or enhance the interaction; (ii) the mechanism
FIGURE 5. Effect of TRPP2 on IP3-induced Ca
2 release in permeabilized
cells. TRPP2/ cells were treated with either a control virus (black) (titer
1/1000) or a TRPP2 virus (red) to re-introduce wild-type TRPP2 (titer 1/1000).
The fluorescence signal (F/F0) of theER-residentCa
2 indicatorMagFluo4was
monitored. After permeabilizing the cells and loading the ER with Ca2, IP3,
TG, or ionomycin were applied as indicated. IP3 was given in the presence of
10MTG to prevent re-uptake of Ca2 into the ER. Panel A shows the [Ca2]ER
(as % of max F/F0) after application of 10 M TG or 1 M ionomycin. Panel B
shows the [Ca2]ER (as % of max F/F0) after application of 3, 20, or 100M IP3.
Mean S.E. of at least three independent experiments are shown.
TABLE 1
Fitting parameters according to the Hill equation of the IP3
dose-response curves
Using 8 different IP3 concentrations (250 and 500 nM, and 1, 3, 5, 20, 50, and 100
M), a complete IP3 dose-response curve for cells expressing wild-type TRPP2 or
control cells was fitted according to the Hill equation. The parameters EC50, Hill
coefficient, and Vmax are depicted. Results are shown as mean S.E. of three inde-
pendent experiments.
Control TRPP2 wild-type p value
EC50 5.77 0.39 3.09 0.05 0.016a
Hill coefficient 1.08 0.09 1.15 0.15 0.435
Vmax 105.73 5.11 103.22 4.33 0.085
a Statistically significant differences with p 	 0.05 using a Student’s t test (paired
two-tailed).
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responsible for the potentiated Ca2 release, which was due to
TRPP2 activity rather than to altered IP3R activity and that
required a close association between TRPP2 and the IP3R to
allow for a Ca2microdomain responsible for the activation of
TRPP2; (iii) the finding that TRPP2 was not responsible for a
passive Ca2 leak from the ER; and (iv) the demonstration of
CICR via TRPP2 in a cellularmodel.We conclude that an acidic
cluster (aa 810–818) in the cytosolic C-terminal tail of TRPP2
and a positively charged cluster (aa 51–54) in the suppressor
region of the LBD in the N terminus of the IP3R were required
FIGURE 6. Effect of TRPP2 mutants, competing peptides, and altered Ca2 buffering conditions on IP3-induced Ca
2 release in permeabilized cells.
A, TRPP2/ cells were treated with either a control virus (black) (titer 1/1000) or a TRPP2 virus to re-introduce wild-type TRPP2 (red) (titer 1/1000) or mutants
D509V (green) (titer 1/704) and R740X (blue) (titer 1/1124). Experiments were performed as described in the legend to Fig. 5 with 3M IP3 andwith 1mM EGTA
for Ca2 buffering. B, TRPP2/ cells were treated with either a control virus (black) (titer 1/1000) or a TRPP2 virus (red) to re-introduce wild-type TRPP2 (titer
1/1000) and assayed as described in the legend to Fig. 5. 1M IP3 was added to the cells in the presence of 10M acidic cluster peptide (AC, closed symbols) or
amutant peptide (ACmutant, open symbols). Experiment was performed in the presence of 1mM EGTA for Ca2 buffering. C, TRPP2/ cells were treatedwith
either a control virus (black) (titer 1/1000) or a TRPP2 virus to re-introducewild-type TRPP2 (red) (titer 1/1000). Experimentswere performed as described in the
legend to Fig. 5 with 5M IP3, except that the Ca
2was bufferedwith 20mMBAPTA instead of 1mM EGTA. The left panels show the results asmean [Ca2]ER (in
% of max F/F0) for at least three independent experiments. The right panels show the percentage Ca
2 release (mean S.E.). Data values were normalized to
the ionomycin-induced Ca2 release, which was taken as 100%, after subtracting the TG-induced Ca2 release. Statistically significant differences are labeled
with: *, p	 0.05, using a Student’s t test (paired two-tailed).
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for their interaction. As a functional consequence of this inter-
action, we found that TRPP2 potentiated IICR. In a previous
study (23) it was postulated that the C-terminal part of TRPP2
could alter the activity of the IP3R. This conclusion was based
on overexpression of the truncated C terminus or the channel-
dead mutant in oocytes. Our data, however, do not provide
evidence for a changed activity of the IP3R as the channel-dead
mutant of TRPP2 had no effect on IICR in our experimental
model, where we have carefully avoided overexpression to
physiologically irrelevant levels. Rather, the enhanced Ca2
release was most likely due to activation of CICR via TRPP2.
This was concluded from our observation that the potentiation
of IICR by TRPP2 was abolished in strong Ca2-buffering
conditions using 20 mM BAPTA, which reduces the
microdomain of the elevated free [Ca2] (41). The difference
between slow (EGTA) or fast (BAPTA) Ca2 buffering is an
established method to estimate the importance of the local
[Ca2]cyt rise in a microdomain close to Ca2-release chan-
nels. For this observed CICR, activation by a local [Ca2]cyt
rise following IICR and the close proximity of the IP3R via a
direct interaction with TRPP2 appeared to be required. The
latter was also evident from our observation that a truncated
TRPP2, which lacks the IP3R-binding site, did not provoke
this potentiation of IICR. Moreover, the effect was also abol-
ished by a peptide competing for the IP3R-binding site. An
additional support for the importance of a close interaction
between TRPP2 and the IP3R stems from the observation
that a global [Ca2]cyt rise as provoked by ionomycin or TG
did not result in an increased TRPP2-induced Ca2 signal.
We propose a model (Fig. 8) where upon cell stimulation IP3
is produced and activates the IP3R, which leads to a local
[Ca2]cyt rise that subsequently can activate the TRPP2
channel as a CICR channel. Previous lipid-bilayer experi-
ments have demonstrated regulation of the open probability
of the TRPP2 channel by Ca2 (25).
Besides important functions of TRPP2 at the plasma mem-
brane and the primary cilia, we now suggest another critical
function for TRPP2 in the ER. We propose the existence of a
signalingmicrodomain that requires a functional TRPP2/IP3R-
protein complex to facilitate CICR by TRPP2. TRPP2 partici-
pates in an intracellular channel complex and potentiates intra-
cellular IP3-mediated Ca2 signaling. It has been shown in lipid
bilayer experiments that TRPP2 is a Ca2-dependent cation
channel, whose activity shows a bell-shaped dependence on
[Ca2]cyt (15, 25). The activation phase of the CICR via TRPP2
was reported to have micromolar affinity (25). Given the rela-
FIGURE 7. Effect of TRPP2 on ionomycin-induced Ca2 release in intact and permeabilized cells. TRPP2/ cells were treated with either control virus
(black) (titer 1/1000) or a TRPP2 virus to re-introduce wild-type TRPP2 (red) (titer 1/1000). A, the ratio of emitted fluorescence of Fura2 was monitored and six
different ionomycin concentrations were added as indicated in the presence of 3 mM EGTA. [Ca2]cyt was derived after in situ calibration. Panel A shows the
averaged traces of at least three independent experiments. B, experiments were performed as described in the legend to Fig. 5 with the indicated ionomycin
concentrations and with 1 mM EGTA for Ca2 buffering. Results are shown as mean [Ca2]ER (as % of max F/F0) S.E. for three independent experiments.
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tively high [Ca2] predicted at the mouth of the IP3R at the ER
surface (34, 42), a micromolar affinity for Ca2 may allow
TRPP2 to sense such local changes in [Ca2]cyt. Recent studies
on the structure of the EF-handwithin the cytosolic C terminus
of TRPP2 have brought new insights into the conformational
changes that occur upon Ca2 binding (6, 8). However, the
direct link between Ca2 binding to the EF-hand of TRPP2 and
its Ca2-dependent channel regulation has not been demon-
strated yet and requires further research. Furthermore, loss of
phosphorylation of TRPP2 (Ser810) can shift the bell-shaped
[Ca2]cyt dependence of TRPP2 channel activity to the right
(25). Given our results from the binding assay with the phos-
phomimic acidic cluster peptide (Fig. 3B), reduced binding
of TRPP2 to the IP3R may be one of the mechanisms respon-
sible for the observed decrease in sensitivity to Ca2 upon
dephosphorylation.
Intracellular Ca2 signaling modulated by TRPP2 is impor-
tant for regulating various cellular processes including cell pro-
liferation. Loss of TRPP2 results in increased cell proliferation
in ADPKD and this is one of the mechanisms leading to cyst
formation (5, 43). It has been reported that ADPKD cystic cells
have a lower [Ca2]cyt, probably due to a loss of TRPP2 channel
function (44). Increased levels of cAMP and cAMP-dependent
genes (such as aquaporin 2) are also a common finding in the
kidneys of different ADPKD animal models. In ADPKD or
under Ca2 deprivation conditions, cAMP stimulates cell pro-
liferation in an Src-, Ras-, and B-Raf-dependentmanner (45). In
view of the role of Ca2 in the regulation of cAMPmetabolism
via Ca2-inhibitable adenylyl cyclase 6 and/or via Ca2-depen-
dent phosphodiesterase-1, it has already been suggested that
alterations in intracellular Ca2 homeostasis account for the
increase in cAMP levels (5). It is tempting to speculate that the
increasedCa2 signaling in IP3R/TRPP2microdomainsmay be
operative in controlling cellular cAMP levels by Ca2 inhibit-
able adenylyl cyclases. Taken together, the previous findings
strongly suggest that themechanisms regulating [Ca2]cyt form
potential therapeutic targets for ADPKD.
Not only proliferation, but also apoptosis is an important
Ca2-regulated cellular process that is impaired in ADPKD,
although this might be rather a consequence than a cause of
cyst formation. Recently, Wegierski et al. (27) have proposed a
role for ER-located TRPP2 in apoptosis. They have found that
TRPP2 can lower the ER Ca2 content, thereby protecting
against apoptosis. In contrast to our data and previous work
(15, 23), they observed that TRPP2 diminished cytosolic and
mitochondrial Ca2 signals induced by IP3R activation.
Because they observed a decreased ER Ca2 content in TRPP2
overexpressing cells, it appeared that those cells have a dimin-
ished Ca2 release upon IP3R activation. In contrast, we could
neither detect a change in [Ca2]ER nor in passive Ca2 leak
(Fig. 5A and supplemental Fig. S7), and we consistently
observed an increase in IICR (Fig. 5B). A difference in our
experimental cell model is that we did not overexpress TRPP2,
but chose expression levels comparable with endogenous levels
of TRPP2 (supplemental Fig. S4). In basal conditions, the
TRPP2 channel is expected to be silent and inhibited by the
endogenous protein syntaxin-5 (46). When TRPP2 is overex-
pressed, it is possible that the endogenous level of syntaxin-5 is
not sufficient to maintain this basal inhibition of TRPP2.
In summary, we observed a clear interaction between TRPP2
and the IP3R and identified a conserved positively charged clus-
ter in the N-terminal suppressor domain of the IP3R and an
acidic cluster located at the end of the ER-retention signal in the
C terminus of TRPP2 as being crucial for their interaction.
When full-length TRPP2 was re-introduced in TRPP2/
mouse renal epithelial cells, there was a clear potentiation of
agonist-induced intracellular Ca2 release in intact cells and
IICR in permeabilized cells. Further analysis using pathological
mutants of TRPP2 and competing peptides revealed that this
effect on IICR was dependent on the TRPP2 channel function
and on the interaction with the IP3R. We propose a model in
which the TRPP2 channel itself is activated as a CICR channel
by a local [Ca2]cyt rise generated by IICR (Fig. 8).
We conclude that a signaling complex involving TRPP2 and
the IP3R is important for modulating intracellular Ca2
signaling. Disturbance of this interaction, which occurs in
pathologically relevant mutants of TRPP2, will lead to altered
intracellular Ca2 homeostasis and might contribute to the
development of ADPKD caused by loss-of-function mutations
in TRPP2.
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